When the environment changes dramatically, animals from mollusks to crows can make big changes in their behavior that enable ...
New research is significantly revising a widely cited evolutionary model, the Inhibitory Cascade Mode (ICM). Benjamin Auerbach, professor in the Department of Ecology and Evolutionary Biology at the ...
Evaluation of operational parameters for clinical evaluation of skin hydration by corneometry method
The Corneometer CM® 825 from Courage & Khazaka electronic GmbH is widely utilized in clinical efficacy testing of cosmetics. Assessing methodological variables is crucial for ensuring the reliability ...
The biotechnology company released an organ-on-chip platform using primate cells to model immune-related diseases for drug ...
The integrated organ-on-chip platform offers 10--100x cost efficiency and 80% reduction in animal use, bridging the gap between preclinical NHP research and human clinical success. SUZHOU, China, SAN ...
Correct fertiliser spreading boosts pasture yields and farm profits. Learn why bout width, calibration, and product quality ...
Based on DESTINY-Breast05 phase 3 trial results, which showed ENHERTU reduced the risk of invasive disease recurrence or death by 53% compared to T-DM1 If approved, Daiichi Sankyo and AstraZeneca’s ...
The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for ENHERTU(R) (trastuzumab deruxtecan) in combination with pertuzumab for the first-line ...
Based on DESTINY-Breast09 phase 3 trial results that showed Daiichi Sankyo and AstraZeneca’s ENHERTU in combination with pertuzumab significantly improved progression-free survival versus current ...
Background: Recent findings indicate that high glycemic variability (GV) could increase the risk of adverse outcomes in patients with cardiovascular disease. With the advances in technology, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results